bifemelane has been researched along with Arterial Obstructive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa, M; Mitsuka, M; Tobe, A; Umezu, K | 1 |
| Asanuma, M; Iwata, E; Kondo, Y; Matsuura, K; Nishibayashi, K; Ogawa, N | 1 |
2 other study(ies) available for bifemelane and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on survival time and brain monoamine levels in bilaterally carotid-artery-ligated gerbils.
Topics: Animals; Arterial Occlusive Diseases; Benzhydryl Compounds; Biogenic Amines; Brain Chemistry; Brain Ischemia; Carotid Artery Diseases; Gerbillinae; Ligation; Male; Norepinephrine; Serotonin | 1984 |
Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion.
Topics: Animals; Arterial Occlusive Diseases; Benzhydryl Compounds; Blotting, Northern; Brain Ischemia; Chronic Disease; Disease Models, Animal; Frontal Lobe; Gene Expression; Hippocampus; Male; Muscarinic Antagonists; Neostriatum; Nootropic Agents; Quinuclidinyl Benzilate; Rats; Rats, Wistar; Receptors, Muscarinic; RNA, Messenger; Tritium | 1996 |